Signaling and targeting cellular pathways in leukaemia metabolism

Whole genome sequence analysis for acute lymphoblastic leukaemia

Use of mesenchymal stromal cells against graft-versus-host disease

Next generation sequencing and the monoclonal structure of multiple myeloma

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Highlights and goals of IMPAKT 2012

PI3K and the heterogeneity of small tumour breast cancer

Heterogeneity of tumours and the challenges of biomarker development

Targeting the cancer genome

Anti-angiogenic agents and cancer stem cells

Mouse models of metastatic breast cancer

Analysis of thirty years of clinical trial data